TGTX - Why Precision BioSciences Stock Is Up Today | Benzinga
Precision BioSciences, Inc. (NASDAQ: DTIL) shares are trading higher Tuesday after the company announced it has signed a licensing agreement with TG Therapeutics, Inc. (NASDAQ: TGTX).
The Details:
Precision announced the completion of a strategic transaction with TG Therapeutics, Inc. for an exclusive license to develop Azercabtagene Zapreleucel (azer-cel) for autoimmune diseases. Precision will receive $17.5 million in upfront and near-term payments with the potential for up to $288 ...